Connect with us

Politics

Institutional Investors Adjust Stakes in Colgate-Palmolive Shares

editorial

Published

on

Kennon Green & Company LLC has decreased its holdings in the Colgate-Palmolive Company by 3.1% during the second quarter of 2023, according to a report from Holdings Channel. The investment firm now owns 11,832 shares of the consumer goods giant after selling 374 shares during this period. Colgate-Palmolive represents a modest 0.9% of Kennon Green’s total portfolio, ranking as its 29th largest investment. As of the latest filing with the Securities and Exchange Commission, these shares are valued at approximately $1.09 million.

Several institutional investors have also modified their positions in Colgate-Palmolive recently. Mutual Advisors LLC increased its stake by 5.1%, bringing its total to 8,265 shares worth $727,000 after acquiring an additional 401 shares. Generali Asset Management SPA SGR notably expanded its holdings by 54.9%, now owning 101,806 shares valued at $9.25 million following the purchase of 36,072 shares.

Ritholtz Wealth Management raised its stake by 5.8%, owning 65,175 shares now worth $5.92 million after adding 3,544 shares. Curated Wealth Partners LLC increased its investment by 14.9%, holding 12,170 shares valued at $1.11 million, while Private Wealth Asset Management LLC boosted its position by 4.3%, bringing its total to 11,954 shares worth $1.09 million. Overall, institutional investors and hedge funds control 80.41% of Colgate-Palmolive’s stock.

Colgate-Palmolive’s Financial Performance

As of the latest trading session, Colgate-Palmolive shares opened at $78.43. The company has a market capitalization of $63.39 billion and a price-to-earnings (P/E) ratio of 22.03, indicating a relatively stable valuation in the consumer goods sector. The stock has a 50-day moving average price of $82.34 and a 200-day moving average price of $87.67. Over the past twelve months, the stock has fluctuated between a low of $76.68 and a high of $102.61.

Colgate-Palmolive recently announced a quarterly dividend of $0.52, set to be paid on November 14, 2023, to shareholders of record on October 17, 2023. This dividend equates to an annualized payout of $2.08, resulting in a dividend yield of 2.7%. The company’s current dividend payout ratio stands at 58.43%, indicating a balanced approach to returning value to shareholders while retaining capital for growth.

Analyst Insights and Market Outlook

Analysts have recently adjusted their price targets for Colgate-Palmolive shares. Bank of America reduced its target from $98.00 to $88.00, maintaining a “buy” rating. Morgan Stanley lowered its price objective from $104.00 to $96.00 with an “overweight” rating.

Barclays adjusted its target price from $87.00 to $82.00, assigning an “equal weight” rating. Similarly, JPMorgan Chase & Co. decreased its price target from $95.00 to $88.00 while keeping an “overweight” rating. UBS Group also revised its target from $99.00 to $92.00, maintaining a “buy” recommendation.

Currently, the stock has received eight “buy” ratings, five “hold” ratings, and one “sell” rating from analysts. According to MarketBeat, Colgate-Palmolive holds an average rating of “Moderate Buy” with an average target price of $92.21.

Colgate-Palmolive Company, along with its subsidiaries, produces and markets consumer products globally. The company operates through two primary segments: Oral, Personal and Home Care, and Pet Nutrition, offering a diverse range of products that include toothpaste, shampoos, and household cleaners. As institutional investors continue to navigate their positions in the company, the outlook for Colgate-Palmolive remains a topic of interest among market watchers.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.